• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCoronavirus

Highly transmissible U.K. virus strain is also 30% more lethal, Boris Johnson warns

Jeremy Kahn
By
Jeremy Kahn
Jeremy Kahn
Editor, AI
Down Arrow Button Icon
Jeremy Kahn
By
Jeremy Kahn
Jeremy Kahn
Editor, AI
Down Arrow Button Icon
January 22, 2021, 1:19 PM ET

The mutant coronavirus strain that first emerged in recent months in the U.K. is 30% more deadly than original virus, British Prime Minister Boris Johnson announced Friday.

Previously, the U.K. government had said that this particular virus strain spread much more easily than the original version of SARS-CoV-2, the virus the causes COVID-19, but that it did not believe it was any more lethal. Friday’s announcement reverses that assessment.

A panel of scientists that advises the British government on the threat posed by emerging respiratory viruses made the new assessment based on data from people testing positive who subsequently died in the U.K. It concluded that there was a 1.3-fold increase in the risk of death, Neil Ferguson, an epidemiologist at Imperial College London who sits on the advisory body, told Britain’s ITV News.

Ferguson said that this meant that for every 1,000 people aged 60 who contracted the new strain of the virus, 13 would likely die, compared to 10 with the original strain.

The U.K. is currently facing the highest daily death tolls since the pandemic began. On Wednesday, 1,820 were reported dead after testing positive for COVID-19 in the U.K., a record high. Since the pandemic began, more than 94,500 people have died in the U.K. from the virus, and the country has the highest death toll per capita of any major country.

Vallance has said that the new strain, which emerged in southern England in October, is between 30% and 70% more transmissible than the original virus. That increase was a major rationale for the new national lockdown in Britain. Meanwhile, many other nations, including the U.S., have imposed much more stringent travel restrictions on arrivals from the U.K., in most cases requiring negative COVID tests of all travelers.

In an evening press conference Friday, Johnson was at pains to emphasize that the new findings about the mutant strain’s lethality did not change scientists’ assessments that the coronavirus vaccines currently being used in the U.K. would still be highly effective against the mutant strain.

The British government has approved three coronavirus vaccines so far, including those produced by Pfizer, AstraZeneca and Moderna. To date, 5.38 million Britons, or about 8% of the country’s population, have received one dose of either the Pfizer or the AstraZeneca vaccine. But it is also thought that about 1 in every 55 people in England is currently infected with coronavirus, according to Chris Whitty, the government’s chief medical officer.

Since first being identified, this particular virus variant has been found in at least 60 countries, including the U.S. In the U.K., this new strain is now the dominant one in many parts of the country.

Meanwhile, the South African variant has also reached Britian. Vallance says the latest PHE data suggests at least 44 people have been detected with the South African variant. There’s no evidence the South African and Brazilian variants are able to transmit more quickly or take over and become the dominant variant, he says.

Anthony Fauci, the director of the U.S. National Institute of Allergy and Infectious Diseases, said at a White House press briefing yesterday that the U.K. strain of the virus has so far been found in at least 20 U.S. states and that the federal government was monitoring the situation carefully. He said it was not clear yet whether the U.K. strain would become more dominant in the U.S. than the original virus.

Fauci said he was less concerned about the U.K. strain, because the existing vaccines seemed to work against it, than he was about other versions of the virus, which have emerged in South Africa and Brazil. These strains have mutations that mean the current crop of vaccines might not work as well against them, Fauci said. No cases of the South African variant have been found in the U.S. so far, he said.

Some British scientists expressed skepticism about the new analysis about the U.K. variant’s lethality, however.

“Interpreting death rates when ICUs are under massive pressure is potentially misleading,” Jonathan Ball, a professor of virology at the University of Nottingham in England tweeted.

“When ICUs are strained then standard of care can be compromised and death rates increase. Cause and effect is tricky to establish with mathematical models unless you include all the variables.”

About the Author
Jeremy Kahn
By Jeremy KahnEditor, AI
LinkedIn iconTwitter icon

Jeremy Kahn is the AI editor at Fortune, spearheading the publication's coverage of artificial intelligence. He also co-authors Eye on AI, Fortune’s flagship AI newsletter.

See full bioRight Arrow Button Icon

Latest in Health

HealthCommentary
Nicotine pouches offer huge promise—so long as the U.S. doesn’t repeat its mistake with vaping
By Max CunninghamDecember 14, 2025
19 hours ago
Thompson
C-SuiteMedia
Atlantic CEO Nick Thompson on how he learned to ‘just keep moving forward’ after his famous firing at 22
By Nick LichtenbergDecember 14, 2025
20 hours ago
HealthAffordable Care Act (ACA)
A Wisconsin couple was paying $2 a month for an ACA health plan. But as subsidies expire, it’s soaring to $1,600, forcing them to downgrade
By Ali Swenson and The Associated PressDecember 13, 2025
2 days ago
Julian Braithwaite is the Director General of the International Alliance for Responsible Drinking
CommentaryProductivity
Gen Z is drinking 20% less than Millennials. Productivity is rising. Coincidence? Not quite
By Julian BraithwaiteDecember 13, 2025
2 days ago
Nicholas Thompson
C-SuiteBook Excerpt
I took over one of the most prestigious media firms while training for an ultramarathon. Here’s what I learned becoming CEO of The Atlantic
By Nicholas ThompsonDecember 13, 2025
2 days ago
Healthmeal delivery
Factor Meals Review 2025: Tester Approved
By Christina SnyderDecember 12, 2025
2 days ago

Most Popular

placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
3 days ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
3 days ago
placeholder alt text
Uncategorized
Transforming customer support through intelligent AI operations
By Lauren ChomiukNovember 26, 2025
19 days ago
placeholder alt text
Economy
More financially distressed farmers are expected to lose their property soon as loan repayments and incomes continue to falter
By Jason MaDecember 13, 2025
2 days ago
placeholder alt text
Energy
Everything the Trump administration is doing in Venezuela involves oil and regime change—even if the White House won’t admit it
By Jordan BlumDecember 14, 2025
21 hours ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
2 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.